Nutritional Assesment in Patients With Cirrhosis
Sponsor
SUUMC Central Military Hospital Dr Carol Davila (Other)
Overall Status
Recruiting
CT.gov ID
NCT05729438
Collaborator
(none)
50
1
24
2.1
Study Details
Study Description
Brief Summary
This study aims to evaluated nutritional status in patiets with cirrhosis
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Nutritional Assesment in Patients With Cirrhosis
Actual Study Start Date
:
Jan 1, 2023
Anticipated Primary Completion Date
:
Dec 31, 2023
Anticipated Study Completion Date
:
Dec 31, 2024
Outcome Measures
Primary Outcome Measures
- muscle mass improvement [3 months]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 75 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
-
signed informed consent
-
age >18, <75 years old
-
hepatic cirrhosis diagnosis
Exclusion Criteria:
-
refuse to participate/to give consent
-
presence of musculo-skeletal disease previous diagnosed, neuropathic diseases, malignancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Suumc | București | București - Sector1 | Romania | 010825 |
Sponsors and Collaborators
- SUUMC Central Military Hospital Dr Carol Davila
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Bucurica Sandica,
MD,
SUUMC Central Military Hospital Dr Carol Davila
ClinicalTrials.gov Identifier:
NCT05729438
Other Study ID Numbers:
- 559
First Posted:
Feb 15, 2023
Last Update Posted:
Feb 15, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: